XML 29 R17.htm IDEA: XBRL DOCUMENT
v3.21.2

Earnings Per Share | 9 Months Ended
--- | ---
Sep. 30, 2021
Earnings Per Share [Abstract] |
Earnings Per Share | Earnings Per Share
(in thousands, except per common share data) | Three months ended September 30, |  | Nine months ended September 30,
2021 |  | 2020 |  | 2021 |  | 2020
Numerator: |  |  |  |  |  |  |
Net income (loss) from continuing operations | $ | 12,290 |  |  | $ | 1,788 |  |  | $ | 66,069 |  |  | $ | (32,088) |
Net income (loss) attributable to noncontrolling interests(a) | (1,602) |  |  | 3,273 |  |  | (822) |  |  | (20,583) |
Net income (loss) available to The Andersons Inc. common shareholders from continuing operations | $ | 13,892 |  |  | $ | (1,485) |  |  | $ | 66,891 |  |  | $ | (11,505) |
Income (loss) from discontinued operations, net of income taxes | $ | 1,846 |  |  | $ | 427 |  |  | $ | 7,453 |  |  | $ | 3,224 |
Denominator: |  |  |  |  |  |  |
Weighted average shares outstanding – basic | 33,284 |  |  | 32,962 |  |  | 33,246 |  |  | 32,905 |
Effect of dilutive awards | 350 |  |  | — |  |  | 424 |  |  | — |
Weighted average shares outstanding – diluted | 33,634 |  |  | 32,962 |  |  | 33,670 |  |  | 32,905 |
Earnings (loss) per share attributable to The Andersons, Inc. common shareholders: |  |  |  |  |  |  |
Basic earnings (loss): |  |  |  |  |  |  |
Continuing operations | $ | 0.42 |  |  | $ | (0.04) |  |  | $ | 2.01 |  |  | $ | (0.35) |
Discontinued operations | 0.06 |  |  | 0.01 |  |  | 0.22 |  |  | 0.10 |
| $ | 0.48 |  |  | $ | (0.03) |  |  | $ | 2.23 |  |  | $ | (0.25) |
Diluted earnings (loss): |  |  |  |  |  |  |
Continuing operations | $ | 0.41 |  |  | $ | (0.04) |  |  | $ | 1.99 |  |  | $ | (0.35) |
Discontinued operations | 0.05 |  |  | 0.01 |  |  | 0.22 |  |  | 0.10 |
| $ | 0.46 |  |  | $ | (0.03) |  |  | $ | 2.21 |  |  | $ | (0.25) |
(a) All net income (loss) attributable to noncontrolling interests is within the continuing operations of the Company. There were 80 thousand antidilutive share awards outstanding for both the three and nine months ended September 30, 2021, respectively. All awards were antidilutive for the three and nine months ended September 30, 2020 as the Company incurred a net loss in both periods.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration